Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
World Journal of Clinical Oncology|March 30, 2013
Ovarian cancer and DNA repair: DNA ligase IV as a potential keyJoana Assis, Deolinda Pereira, Rui MedeirosOncology Letters|March 15, 2019
Pain prevalence and treatment in patients with metastatic bone diseaseCláudia Vieira, Maria Fragoso, Deolinda Pereira, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|November 6, 2019
Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviourValéria Tavares, Ricardo Pinto, Joana Assis, et al.Cureus|February 24, 2022
Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical DataMaria Leitão, Sarah Lopes, Deolinda Pereira, et al.Current Issues in Molecular Biology|May 24, 2024
Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk ComponentInês Guerra de Melo, Valéria Tavares, Deolinda Pereira, et al.European Journal of Clinical Pharmacology|January 25, 2016
Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profileDeolinda Pereira, Joana Assis, Mónica Gomes, et al.Data in Brief|April 8, 2020
Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressivenessValéria Tavares, Ricardo Pinto, Joana Assis, et al.Gynecologic Oncology Reports|March 4, 2022
Impressive and durable clinical responses obtained with dabrafenib and trametinib in low-grade serous ovarian cancer harbouring a BRAF V600E mutationBárbara Lima, Miguel Henriques Abreu, Susana Sousa, et al.Molecular Medicine Reports|December 29, 2018
Pain polymorphisms and opioids: An evidence based reviewCláudia Margarida Pereira Vieira, Rosa Maria Fragoso, Deolinda Pereira, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 24, 2004
Loss of beta-catenin is associated with poor survival in ovarian carcinomasCristina Faleiro-Rodrigues, Isabel Macedo-Pinto, Deolinda Pereira, et al.Pageof 9